Published :
Tables : 57
Figures : 51
Category : Healthcare
No. of Pages : 245
Report Code : HC-U5392
Genetic Counseling Market is poised to value over CAGR of over 13.8% during the forecast period 2022 to 2028. FutureWise Market Research has instantiated a report that provides an intricate analysis of Genetic Counseling Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market. According to the research study conducted by FutureWise research analysts, the Genetic Counseling Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical. Major players included in the Genetic Counseling Market: • AT-GC • Ancestry • Arup Laboratories • Biron Health Group • Color Genomics • EasyDNA • GenPath Diagnostics (an Opko Health Company) • GeneDX (an Opko Health Company) • GeneHealth UK • GeneMatters • GeneScreen • Genome Medical • InformedDNA • Invitae Corporation • Laboratory Corporation of America • Metis Genetics • MyOncoPath • Quest Diagnostics Incorporated • Veritas Genetics (Note: The list of the major players will be updated with the latest market scenario and trends) Genetic Counseling Market Segmentation: By Counseling Approach • Integrated • Independent • Discretionary Genetic Counseling By Key Players Business Model • Core Genetic Counseling Companies • Direct-to-Consumer Genetic Testing Companies • Clinical Genetic Testing Companies By Channel • Providers • Self-Referred Individuals By Type of Service • Risk Assessment • Pharmacogenomics • Other Genetic Counseling Services By Application • Proactive Risk Assessment • GC For Intent-to-Treat Patients (ITT) • Prenatal and Preconception Care • Pediatric Care • Other Genetic Counseling Applications By Target Population Segment • General Population • Patient Population By Level of Service • Pre-counseling Support • Post Counseling Support By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa Genetic Counseling Market Video Sample: Competitive Landscape: • Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key trends • Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on the Genetic Counseling Market By Counseling Approach, By Key Players Business Model, By Channel, By Type of Service, By Application, By Target Population Segment, By Level of Service and By Region. • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa. • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
FutureWise Market Research has instantiated a report that provides an intricate analysis of Genetic Counseling Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market. According to the research study conducted by FutureWise research analysts, the Genetic Counseling Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical. Major players included in the Genetic Counseling Market: • AT-GC • Ancestry • Arup Laboratories • Biron Health Group • Color Genomics • EasyDNA • GenPath Diagnostics (an Opko Health Company) • GeneDX (an Opko Health Company) • GeneHealth UK • GeneMatters • GeneScreen • Genome Medical • InformedDNA • Invitae Corporation • Laboratory Corporation of America • Metis Genetics • MyOncoPath • Quest Diagnostics Incorporated • Veritas Genetics (Note: The list of the major players will be updated with the latest market scenario and trends) Genetic Counseling Market Segmentation: By Counseling Approach • Integrated • Independent • Discretionary Genetic Counseling By Key Players Business Model • Core Genetic Counseling Companies • Direct-to-Consumer Genetic Testing Companies • Clinical Genetic Testing Companies By Channel • Providers • Self-Referred Individuals By Type of Service • Risk Assessment • Pharmacogenomics • Other Genetic Counseling Services By Application • Proactive Risk Assessment • GC For Intent-to-Treat Patients (ITT) • Prenatal and Preconception Care • Pediatric Care • Other Genetic Counseling Applications By Target Population Segment • General Population • Patient Population By Level of Service • Pre-counseling Support • Post Counseling Support By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa
Genetic Counseling Market Video Sample:
Competitive Landscape: • Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key trends • Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on the Genetic Counseling Market By Counseling Approach, By Key Players Business Model, By Channel, By Type of Service, By Application, By Target Population Segment, By Level of Service and By Region. • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa. • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
1. Market Introduction 1.1 Objectives of the Study 1.2 Market Definition 1.3 Market Scope 1.3.1 Years Considered for the Study 1.3.2 Market Covered 1.4 Currency 1.5 Limitations 1.6 Stakeholders 2. Research Methodology 2.1 Research Data 2.1.1 Secondary Data 2.1.1.1 Key Data from Secondary Sources 2.1.2 Primary Data 2.1.2.1 Key Data from Primary Sources 2.2 Market Size Estimation 2.3 Market Breakdown and Data Triangulation 2.4 Assumptions for the Study 3. Executive Summary 3.1 Market Outlook 3.2 Segment Outlook 3.3 Competitive Insights 4. Global Genetic Counseling Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Genetic Counseling Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Global Genetic Counseling Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Global Genetic Counseling Market, By Counseling Approach Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. Integrated 7.2. Independent 7.3. Discretionary Genetic Counseling 8. Global Genetic Counseling Market, By Key Players Business Model Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Core Genetic Counseling Companies 8.2. Direct-to-Consumer Genetic Testing Companies 8.3. Clinical Genetic Testing Companies 9. Global Genetic Counseling Market, By Channel Historical Analysis and Forecast 2022-2028 (USD Million) 9.1. Providers 9.2. Self-Referred Individuals 10. Global Genetic Counseling Market, By Type of Service Historical Analysis and Forecast 2022-2028 (USD Million) 10.1. Risk Assessment 10.2. Pharmacogenomics 10.3. Other Genetic Counseling Services 11. Global Genetic Counseling Market, By Application Historical Analysis and Forecast 2022-2028 (USD Million) 11.1. Proactive Risk Assessment 11.2. GC For Intent-to-Treat Patients (ITT) 11.3. Prenatal and Preconception Care 11.4. Pediatric Care 11.5. Other Genetic Counseling Applications 12. Global Genetic Counseling Market, By Target Population Segment Historical Analysis and Forecast 2022-2028 (USD Million) 12.1. General Population 12.2. Patient Population 13. Global Genetic Counseling Market, By Level of Service Historical Analysis and Forecast 2022-2028 (USD Million) 13.1. Pre-counseling Support 13.2. Post Counseling Support 14. North America Genetic Counseling Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. U.S.A 14.2.2. Canada 14.2.3. Mexico 14.3. Market Size (USD Million) Forecast for North America 2022-2028 15. Latin America Genetic Counseling Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 15.1. Introduction 15.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 15.2.1. Brazil 15.2.2. Venezuela 15.2.3. Argentina 15.2.4. Rest of Latin America 15.3. Market Size (USD Million) Forecast for Latin America 2022-2028 16. Europe Genetic Counseling Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 16.1. Introduction 16.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 16.2.1. Germany 16.2.2. U.K 16.2.3. France 16.2.4. Italy 16.2.5. Spain 16.2.6. Russia 16.2.7. Poland 16.2.8. Rest of Europe 16.3. Market Size (USD Million) Forecast for Europe 2022-2028 17. Asia Pacific Genetic Counseling Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 17.1. Introduction 17.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 17.2.1. Japan 17.2.2. China 17.2.3. India 17.2.4. Australia and New Zealand 17.2.5. ASEAN 17.2.6. Rest of Asia Pacific 17.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028 18. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 18.1. Introduction 18.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 18.2.1. GCC 18.2.2. Israel 18.2.3. South Africa 18.2.4. Rest of MEA 18.3. Market Size (USD Million) Forecast for MEA 2022-2028 19. Market Share Analysis and Competitive Landscape 19.1. Global Landscape - Key Players, Revenue and Presence 19.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 19.3. Global Emerging Companies 19.4. North America - Market Share Analysis and Key Regional Players 19.5. Europe - Market Share Analysis and Key Regional Players 19.6. Asia Pacific - Market Share Analysis and Key Regional Players 19.7. Global Key Player - Growth Matrix 20. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 20.1. AT-GC 20.1.1. Company Overview 20.1.2. Product Portfolio 20.1.3. SWOT Analysis 20.1.4. Financial Overview 20.1.5. Strategic Overview 20.2. Ancestry 20.2.1. Company Overview 20.2.2. Product Portfolio 20.2.3. SWOT Analysis 20.2.4. Financial Overview 20.2.5. Strategic Overview 20.3. Arup Laboratories 20.3.1. Company Overview 20.3.2. Product Portfolio 20.3.3. SWOT Analysis 20.3.4. Financial Overview 20.3.5. Strategic Overview 20.4. Biron Health Group 20.4.1. Company Overview 20.4.2. Product Portfolio 20.4.3. SWOT Analysis 20.4.4. Financial Overview 20.4.5. Strategic Overview 20.5. Color Genomics 20.5.1. Company Overview 20.5.2. Product Portfolio 20.5.3. SWOT Analysis 20.5.4. Financial Overview 20.5.5. Strategic Overview 20.6. EasyDNA 20.6.1. Company Overview 20.6.2. Product Portfolio 20.6.3. SWOT Analysis 20.6.4. Financial Overview 20.6.5. Strategic Overview 20.7. GenPath Diagnostics (an Opko Health Company) 20.7.1. Company Overview 20.7.2. Product Portfolio 20.7.3. SWOT Analysis 20.7.4. Financial Overview 20.7.5. Strategic Overview 20.8. GenPath Diagnostics (an Opko Health Company) 20.8.1. Company Overview 20.8.2. Product Portfolio 20.8.3. SWOT Analysis 20.8.4. Financial Overview 20.8.5. Strategic Overview 20.9. GeneHealth UK 20.9.1. Company Overview 20.9.2. Product Portfolio 20.9.3. SWOT Analysis 20.9.4. Financial Overview 20.9.5. Strategic Overview 20.10.GeneMatters 20.10.1. Company Overview 20.10.2. Product Portfolio 20.10.3. SWOT Analysis 20.10.4. Financial Overview 20.10.5. Strategic Overview 20.11.GeneScreen 20.11.1. Company Overview 20.11.2. Product Portfolio 20.11.3. SWOT Analysis 20.11.4. Financial Overview 20.11.5. Strategic Overview 20.12.Genome Medical 20.12.1. Company Overview 20.12.2. Product Portfolio 20.12.3. SWOT Analysis 20.12.4. Financial Overview 20.12.5. Strategic Overview 20.13.InformedDNA 20.13.1. Company Overview 20.13.2. Product Portfolio 20.13.3. SWOT Analysis 20.13.4. Financial Overview 20.13.5. Strategic Overview 20.14.Invitae Corporation 20.14.1. Company Overview 20.14.2. Product Portfolio 20.14.3. SWOT Analysis 20.14.4. Financial Overview 20.14.5. Strategic Overview 20.15.Laboratory Corporation of America 20.15.1. Company Overview 20.15.2. Product Portfolio 20.15.3. SWOT Analysis 20.15.4. Financial Overview 20.15.5. Strategic Overview 20.16.Metis Genetics 20.16.1. Company Overview 20.16.2. Product Portfolio 20.16.3. SWOT Analysis 20.16.4. Financial Overview 20.16.5. Strategic Overview 20.17.MyOncoPath 20.17.1. Company Overview 20.17.2. Product Portfolio 20.17.3. SWOT Analysis 20.17.4. Financial Overview 20.17.5. Strategic Overview 20.18.Quest Diagnostics Incorporated 20.18.1. Company Overview 20.18.2. Product Portfolio 20.18.3. SWOT Analysis 20.18.4. Financial Overview 20.18.5. Strategic Overview 20.19.Veritas Genetics 20.19.1. Company Overview 20.19.2. Product Portfolio 20.19.3. SWOT Analysis 20.19.4. Financial Overview 20.19.5. Strategic Overview 21. Pre and Post COVID-19 Impact 21.1. Positive influence on the healthcare industry 21.2. The financial disruption of the manufacturing sector 21.3. Impact of COVID-19 on emerging companies 21.4. Significant mandates in the healthcare regulations initiated by administrations 21.5. The overall economic slowdown of the developing and developed nations 22. FutureWise SME Key Takeaway Points for Client
1. Market Introduction 1.1 Objectives of the Study 1.2 Market Definition 1.3 Market Scope 1.3.1 Years Considered for the Study 1.3.2 Market Covered 1.4 Currency 1.5 Limitations 1.6 Stakeholders
2. Research Methodology 2.1 Research Data 2.1.1 Secondary Data 2.1.1.1 Key Data from Secondary Sources 2.1.2 Primary Data 2.1.2.1 Key Data from Primary Sources 2.2 Market Size Estimation 2.3 Market Breakdown and Data Triangulation 2.4 Assumptions for the Study
3. Executive Summary 3.1 Market Outlook 3.2 Segment Outlook 3.3 Competitive Insights
4. Global Genetic Counseling Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances
5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Genetic Counseling Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Global Genetic Counseling Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies
7. Global Genetic Counseling Market, By Counseling Approach Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. Integrated 7.2. Independent 7.3. Discretionary Genetic Counseling
8. Global Genetic Counseling Market, By Key Players Business Model Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Core Genetic Counseling Companies 8.2. Direct-to-Consumer Genetic Testing Companies 8.3. Clinical Genetic Testing Companies
9. Global Genetic Counseling Market, By Channel Historical Analysis and Forecast 2022-2028 (USD Million) 9.1. Providers 9.2. Self-Referred Individuals
10. Global Genetic Counseling Market, By Type of Service Historical Analysis and Forecast 2022-2028 (USD Million) 10.1. Risk Assessment 10.2. Pharmacogenomics 10.3. Other Genetic Counseling Services 11. Global Genetic Counseling Market, By Application Historical Analysis and Forecast 2022-2028 (USD Million) 11.1. Proactive Risk Assessment 11.2. GC For Intent-to-Treat Patients (ITT) 11.3. Prenatal and Preconception Care 11.4. Pediatric Care 11.5. Other Genetic Counseling Applications
12. Global Genetic Counseling Market, By Target Population Segment Historical Analysis and Forecast 2022-2028 (USD Million) 12.1. General Population 12.2. Patient Population
13. Global Genetic Counseling Market, By Level of Service Historical Analysis and Forecast 2022-2028 (USD Million) 13.1. Pre-counseling Support 13.2. Post Counseling Support
14. North America Genetic Counseling Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. U.S.A 14.2.2. Canada 14.2.3. Mexico 14.3. Market Size (USD Million) Forecast for North America 2022-2028
15. Latin America Genetic Counseling Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 15.1. Introduction 15.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 15.2.1. Brazil 15.2.2. Venezuela 15.2.3. Argentina 15.2.4. Rest of Latin America 15.3. Market Size (USD Million) Forecast for Latin America 2022-2028
16. Europe Genetic Counseling Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 16.1. Introduction 16.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 16.2.1. Germany 16.2.2. U.K 16.2.3. France 16.2.4. Italy 16.2.5. Spain 16.2.6. Russia 16.2.7. Poland 16.2.8. Rest of Europe 16.3. Market Size (USD Million) Forecast for Europe 2022-2028
17. Asia Pacific Genetic Counseling Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 17.1. Introduction 17.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 17.2.1. Japan 17.2.2. China 17.2.3. India 17.2.4. Australia and New Zealand 17.2.5. ASEAN 17.2.6. Rest of Asia Pacific 17.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028
18. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 18.1. Introduction 18.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 18.2.1. GCC 18.2.2. Israel 18.2.3. South Africa 18.2.4. Rest of MEA 18.3. Market Size (USD Million) Forecast for MEA 2022-2028
19. Market Share Analysis and Competitive Landscape 19.1. Global Landscape - Key Players, Revenue and Presence 19.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 19.3. Global Emerging Companies 19.4. North America - Market Share Analysis and Key Regional Players 19.5. Europe - Market Share Analysis and Key Regional Players 19.6. Asia Pacific - Market Share Analysis and Key Regional Players 19.7. Global Key Player - Growth Matrix
20. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 20.1. AT-GC 20.1.1. Company Overview 20.1.2. Product Portfolio 20.1.3. SWOT Analysis 20.1.4. Financial Overview 20.1.5. Strategic Overview 20.2. Ancestry 20.2.1. Company Overview 20.2.2. Product Portfolio 20.2.3. SWOT Analysis 20.2.4. Financial Overview 20.2.5. Strategic Overview 20.3. Arup Laboratories 20.3.1. Company Overview 20.3.2. Product Portfolio 20.3.3. SWOT Analysis 20.3.4. Financial Overview 20.3.5. Strategic Overview 20.4. Biron Health Group 20.4.1. Company Overview 20.4.2. Product Portfolio 20.4.3. SWOT Analysis 20.4.4. Financial Overview 20.4.5. Strategic Overview 20.5. Color Genomics 20.5.1. Company Overview 20.5.2. Product Portfolio 20.5.3. SWOT Analysis 20.5.4. Financial Overview 20.5.5. Strategic Overview 20.6. EasyDNA 20.6.1. Company Overview 20.6.2. Product Portfolio 20.6.3. SWOT Analysis 20.6.4. Financial Overview 20.6.5. Strategic Overview 20.7. GenPath Diagnostics (an Opko Health Company) 20.7.1. Company Overview 20.7.2. Product Portfolio 20.7.3. SWOT Analysis 20.7.4. Financial Overview 20.7.5. Strategic Overview 20.8. GenPath Diagnostics (an Opko Health Company) 20.8.1. Company Overview 20.8.2. Product Portfolio 20.8.3. SWOT Analysis 20.8.4. Financial Overview 20.8.5. Strategic Overview 20.9. GeneHealth UK 20.9.1. Company Overview 20.9.2. Product Portfolio 20.9.3. SWOT Analysis 20.9.4. Financial Overview 20.9.5. Strategic Overview 20.10.GeneMatters 20.10.1. Company Overview 20.10.2. Product Portfolio 20.10.3. SWOT Analysis 20.10.4. Financial Overview 20.10.5. Strategic Overview 20.11.GeneScreen 20.11.1. Company Overview 20.11.2. Product Portfolio 20.11.3. SWOT Analysis 20.11.4. Financial Overview 20.11.5. Strategic Overview 20.12.Genome Medical 20.12.1. Company Overview 20.12.2. Product Portfolio 20.12.3. SWOT Analysis 20.12.4. Financial Overview 20.12.5. Strategic Overview 20.13.InformedDNA 20.13.1. Company Overview 20.13.2. Product Portfolio 20.13.3. SWOT Analysis 20.13.4. Financial Overview 20.13.5. Strategic Overview 20.14.Invitae Corporation 20.14.1. Company Overview 20.14.2. Product Portfolio 20.14.3. SWOT Analysis 20.14.4. Financial Overview 20.14.5. Strategic Overview 20.15.Laboratory Corporation of America 20.15.1. Company Overview 20.15.2. Product Portfolio 20.15.3. SWOT Analysis 20.15.4. Financial Overview 20.15.5. Strategic Overview 20.16.Metis Genetics 20.16.1. Company Overview 20.16.2. Product Portfolio 20.16.3. SWOT Analysis 20.16.4. Financial Overview 20.16.5. Strategic Overview 20.17.MyOncoPath 20.17.1. Company Overview 20.17.2. Product Portfolio 20.17.3. SWOT Analysis 20.17.4. Financial Overview 20.17.5. Strategic Overview 20.18.Quest Diagnostics Incorporated 20.18.1. Company Overview 20.18.2. Product Portfolio 20.18.3. SWOT Analysis 20.18.4. Financial Overview 20.18.5. Strategic Overview 20.19.Veritas Genetics 20.19.1. Company Overview 20.19.2. Product Portfolio 20.19.3. SWOT Analysis 20.19.4. Financial Overview 20.19.5. Strategic Overview
21. Pre and Post COVID-19 Impact 21.1. Positive influence on the healthcare industry 21.2. The financial disruption of the manufacturing sector 21.3. Impact of COVID-19 on emerging companies 21.4. Significant mandates in the healthcare regulations initiated by administrations 21.5. The overall economic slowdown of the developing and developed nations
22. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics